Relations between doses cumulated in bone marrow and dose delivery techniques during radiation therapy of cervical and endometrial cancer |
| |
Affiliation: | 5. Departement de radiothérapie, Centre Antoine Lacassagne, Nice;1. University Children''s Hospital, University of Wuerzburg, Josef-Schneider-Str. 2, Wuerzburg, Germany;2. Central Laboratory, University Hospital Innsbruck, Anichstr. 35, Innsbruck, Austria;3. Department of Internal Medicine, Medical University of Innsbruck, Anichstr. 35, Innsbruck, Austria;4. Cardiac Surgery Research Laboratory, Cardiac Surgery, Medical University of Innsbruck, Anichstr. 35, Innsbruck, Austria |
| |
Abstract: | PurposeTo compare normal tissue complication probability (NTCP) and average doses in the bone marrow (BM), obtained for five different radiotherapy delivery and planning strategies of cervical and endometrial cancer.Material/methods50 patients were taken to analysis. For each case, 3 different dose delivery techniques were used: 4-field, X15MV, 3DCRT; 7-field, X6MV, IMRT; and 2-arc, X6MV, VMAT. Two optimization scenarios were used for the IMRT and VMAT plans generation: with (+) and without (−) the inclusion of the BM as an optimized structure. Average doses and dose-volume histogram parameters for the PTV, BM, bladder, rectum, bowels and femoral heads were compared. In addition, the BM doses were analyzed with respect to the PTV and/or volume of the BM, and NTCP for the BM were computed.ResultsThe dose in PTV for evaluated plans was similar. The worst doses in organs at risk were obtained for 3DCRT. Using the BM during the optimization of IMRT and VMAT reduces an average dose in BM without increasing the doses in the bladder, rectum and bowels. Differences between doses in BM for IMRT(+) and VMAT(+) plans were similar while NTCP was lower for VMAT(+). A correlation between average dose in BM and the volume ratio of BM and PTV was found for each technique.ConclusionUsing the BM during the optimization of the IMRT and VMAT plans effectively reduces the dose in BM without increasing the dose in the bladder, rectum and bowels. The VMAT(+) plans were characterized by the lowest NTCP. |
| |
Keywords: | Gynecological cancer Bone marrow Optimization strategies IMRT VMAT NTCP modeling |
本文献已被 ScienceDirect 等数据库收录! |
|